Post by
pelaboost on Sep 09, 2023 7:21am
JNJ & Liver Cancer
@ dude on ST
in re your post about hepatitis c and liver cancer.
Many years ago a respected UK group suggested reolysin, now known as pela, SHOULD, not could, be used in Africa to fight liver cancer. That went nowhere. as ONC was likely trying to stay focussed on limited funds just as now.
I am quite certain of the above but I cannot find the article, and I dare say not overly important as time is not on our side.
The time to put up has arrived.
Comment by
pelaboost on Sep 09, 2023 7:25am
forgot to mention JNJ among others has, or did have an interest in liver cancer. MM is also still very much a part of the puzzle. Nevertheless the chess clock is just about to run out.
Comment by
pelaboost on Sep 09, 2023 7:42am
I thought I remembered that Roche and HCC were a thing. They are. Roche and ONC/Y seem to be very well matched indeed. Could there be a language barrier? Has it do do with money? Patients and shareholders would like to know!
Comment by
fox7mf on Sep 09, 2023 9:03am
All good pts. Clock is ticking...pull the trigger Oncy, an acquisition is long overdue.
Comment by
Lesalpes29 on Sep 09, 2023 9:32am
Let's go Matt and management do what is to be done in the coming week. Shorts and MM are ready to put a lot of pressure on the SP if you miss again!